Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: JAMA. 2010 Apr 14;303(14):1392–1400. doi: 10.1001/jama.2010.409

Appendix 3A.

Time from Symptom Onset to Arrival
Payor Type* ≤ 2 hours
n = 1070
>2 to 6 hours
n = 704
> 6 hours
n = 1208
Unadjusted
OR (95% CI)
P Value
Commercial/PPO 646 (60.4) 325 (46.2) 533 (44.1) Reference Reference
HMO 123 (11.5) 109 (15.5) 199 (16.5) 1.41 (1.16-1.71) <.001
Medicare 192 (17.9) 181 (25.7) 291 (24.1) 1.49 (1.28-1.73) <.001
Medicaid 58 (5.4) 53 (7.5) 94 (7.8) 1.56 (1.23-1.99) <.001
VA 14 (1.3) 7 (1.0) 25 (2.1) 2.06 (1.26-3.36) .004
Other 37 (3.5) 29 (4.1) 66 (5.5) 1.54 (1.13-2.10) .006
*

Patients without health insurance were excluded in this analysis.

HHS Vulnerability Disclosure